Risk-Based Transition/Exit Plans & Knowledge Transfer: Reducing Cost Without Losing Quality or Control
Risk-Based Transition/Exit Plans & Knowledge Transfer: Reducing Cost Without Losing Quality or Control Risk-Based Transition/Exit Plans & Knowledge Transfer: Reducing Cost Without Losing Quality or Control In today’s evolving landscape of clinical trials, particularly within ovarian cancer clinical trials, the need for effective transition and exit strategies has become imperative. This article is a step-by-step…